Cytotoxic agents and haemozoin pigment in malaria parasites (Plasmodium berghei).
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001377:Azaserine / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D002738:Chloroquine / Q000627:therapeutic use; D003513:Cycloheximide / Q000627:therapeutic use; D003593:Cytoplasm / Q000187:drug effects; D003609:Dactinomycin / Q000627:therapeutic use; D007274:Injections, Intraperitoneal; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D051379:Mice; D008937:Mitomycins / Q000627:therapeutic use; D009696:Nucleic Acids / Q000096:biosynthesis; D010860:Pigments, Biological; D010961:Plasmodium / Q000187:drug effects*; D014176:Protein Biosynthesis; D011691:Puromycin / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D014498:Uracil / Q000031:analogs & derivatives / Q000627:therapeutic use
D000970:Antineoplastic Agents; D008937:Mitomycins; D009696:Nucleic Acids; D010860:Pigments, Biological; D003609:Dactinomycin; D011691:Puromycin; D014498:Uracil; D002701:Chloramphenicol; D001377:Azaserine; D002738:Chloroquine; D003513:Cycloheximide; D015122:Mercaptopurine; D013752:Tetracycline; D013307:Streptomycin